MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
about
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancerMicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cellsMicro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2.Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian CancerMicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.MicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1.CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.MiR-101 inhibits ovarian carcinogenesis by repressing the expression of brain-derived neurotrophic factor.MiRNA-101 inhibits oral squamous-cell carcinoma growth and metastasis by targeting zinc finger E-box binding homeobox 1miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells.Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathwayLncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
P2860
Q28082679-F7927FC6-8E16-4FA0-8BF4-32B95D82FD0EQ28273264-D149F637-EDF3-45D3-973A-642C06978512Q28393136-94646EA7-7A78-4CD0-9895-52D5E9BCC406Q35557027-17EEF93A-9EFA-4A2A-A51A-7787CC6F54C0Q36213718-8E231CC8-B2A0-42E2-A5C7-1304FECDE211Q36326301-D11C274D-905A-4711-987A-26CB82F7328BQ36497625-83ABAE4C-6F6B-4995-8768-A44D04FFBA2BQ36742322-1D4E1608-0415-4030-A285-D51DB459CBB1Q37077423-ED172DE3-9715-4338-BB52-0A755864525DQ38719379-2C6474F8-A268-4327-9A7E-E7AB9FA48C29Q38822607-7E4DDF84-2133-4985-A5F3-C0E4E07F036AQ41627612-B38100EC-E9DD-4478-9F4D-ABB287D65215Q42027505-60BB8C27-9A91-4FE2-9D4B-84B068E12C6BQ42722521-427C113E-B503-473B-9B91-730B54243B76Q49593669-07FBB98C-B190-4BB7-BEFF-6A6966EFA7D1Q52598859-D570BC7E-4CD1-4C02-8964-40F3802E7C6AQ52670935-44BAC4BA-2229-4F7E-87B2-FDFF8029B0D9Q52674354-C5DA5C3E-CADA-4ECA-8555-6BFEA28D60CAQ58706941-636B1EFA-DFED-4C82-B293-7F85274AE13AQ58788537-5BEC82FA-4A64-419D-84AB-6E093B472741
P2860
MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@ast
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@en
type
label
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@ast
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@en
prefLabel
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@ast
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@en
P2093
P2860
P356
P1433
P1476
MiR-101 suppresses the epithel ...... and ZEB2 in ovarian carcinoma
@en
P2093
Anil K Sood
David Cogdell
Fengxia Xue
P2860
P304
P356
10.3892/OR.2014.3106
P50
P577
2014-03-21T00:00:00Z